Who Owns SLN?

Silence Therapeutics plc — Institutional Ownership & 13F Holdings

$7.85

+0.15 (+1.95%)

Market Cap

$292.4M

Shares Outstanding

47,233,949

Institutional Holders

59

Total Inst. Value

$63.1M

% of Float Held

QoQ Holder Change

+2

Institutional data as of Q1 2025

New Positions

8

Closed Positions

12

Increased

19

Decreased

22

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1TCG Crossover Management, LLC$8.6M3,033,560
2Siren, L.L.C.$7.9M2,789,833
3Redmile Group, LLC$6.2M2,214,947
4MORGAN STANLEY$5.6M2,000,105
5Lombard Odier Asset Management (USA) Corp$4.0M1,849,734
6GAMMA Investing LLC$3.6M10,039
7Frazier Life Sciences Management, L.P.$3.2M1,148,591
8Vivo Capital, LLC$3.1M1,105,454
9Nantahala Capital Management, LLC$2.9M1,042,427
10Nextech Invest, Ltd.New$2.7M952,400

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
MORGAN STANLEY+337K$5.6M
GAMMA Investing LLC+4K$3.6M
Nextech Invest, Ltd.New+952K$2.7M
CANTOR FITZGERALD, L. P.+234K$2.2M
Saturn V Capital Management LP+337K$2.1M

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold SLN?

As of Q1 2025, 59 institutional investors report holding SLN (Silence Therapeutics plc) in their 13F filings.

Which hedge fund owns the most SLN?

The largest institutional holder of SLN is TCG Crossover Management, LLC with $8.6M in shares.

Are institutions buying or selling SLN?

This quarter, 8 institutions opened new positions in SLN and 12 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.